Outlook in Parliament
Innovative Medicines Canada
Innovative Medicines Canada (IMC) announced the appointment of Gaby Bourbara, president of AstraZeneca Canada, as chair of its Board of Directors. “Gaby brings deep experience, trusted relationships, and an unwavering commitment to collaboration,” said Dr. Bettina Hamelin, president & CEO of Innovative Medicines Canada. “His leadership will help IMC and our members continue to deliver meaningful progress … Read more